SecBot SecBot
SC 13G ·Filed Nov 5, 2026

SLN

Silence Therapeutics plc
NEUTRAL
Impact 4/10
Horizonweeks Processed11d 13h ago SEC0000315066-26-002833
Passive investor 5%+ stake
Actionable Insight • Neutral

Fidelity's new 7.1% passive stake adds to the recent cluster of institutional filings (Tetragon at ~5.2%, Invus via prior amendment). Monitor for any subsequent 13D conversion or additional accumulation by Fidelity, though the passive certification makes activist intent unlikely. The concentration of multiple 5%+ holders may increase stock liquidity and institutional attention.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$19.72
T+0 close · Nov 5, 2026 · via day close
Latest settled
+0.41%
T+5 · $19.80
Vs SPY
−2.88%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $19.72entry
  2. T+1 · 11d ago +0.05%α −0.26% · $19.73
  3. T+5 · 5d ago +0.41%α −2.88% · $19.80
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

FMR LLC (Fidelity) filed a new Schedule 13G disclosing a 7.1% passive stake in Silence Therapeutics plc as of September 30, 2026, representing 13,180,206 common shares. This is a new passive position by a major institutional asset manager, adding to recent passive stake filings by Tetragon and Invus, and signals broad institutional interest without activist intent.

Key Financial Metrics

Stake
7.1%
Investor
FMR LLC (Fidelity)
Investor Type
mutual fund

Key Facts

  • FMR LLC (Fidelity) filed a new Schedule 13G disclosing beneficial ownership of 13,180,206 common shares of Silence Therapeutics plc.
  • The stake represents 7.1% of shares outstanding as of September 30, 2026.
  • The filing certifies passive investment intent under Rule 13d-1(b), with no purpose or effect of changing or influencing control.
  • This is a new position; no prior FMR LLC 13G for Silence Therapeutics was found in the provided context.
  • The filing is dated November 4, 2026, and was accepted by the SEC on November 5, 2026.
  • FMR LLC is a holding company (HC) and its subsidiaries FIAM LLC and Fidelity Management & Research Company LLC are investment advisers (IA).

Financial Impact

FMR LLC holds 13,180,206 shares, representing 7.1% of Silence Therapeutics' outstanding common stock. At a $1.2B market cap, the stake is valued at approximately $85M.

ownership concentration

Risk Factors

  • Passive 13G status could change if Fidelity later engages with management or seeks board representation, triggering a 13D filing.
  • No stated price or date of acquisition; the stake may have been accumulated over time at varying prices.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0000315066-26-002833
Document: 0000315066-26-002833-index-headers.html0000315066-26-002833
Document: 0000315066-26-002833-index.html0000315066-26-002833
Document: 0000315066-26-002833.txt0000315066-26-002833

Track record

15 reports on SLN

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +28.19% at T+60 after the Aug 10, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $19.72 Now $19.80 +0.42% settles Nov 24
  2. Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $19.80 Now $19.80 −0.00% settles Nov 19
  3. Nov 12, 20264d ago DEFA14A Neutral 4/10 Entry $19.80 Now $19.80 −0.00% settles Nov 19
  4. Nov 12, 20264d ago 8-K Neutral 5/10 Entry $19.80 Now $19.80 −0.00% settles Nov 19
  5. Nov 5, 202611d ago SC 13G Neutral 4/10 Viewing Entry $19.72 to $19.80 Now $19.80 +0.41% ▲ +0.41% −2.88% vs SPY
  6. Oct 19, 202628d ago DEFA14A Bullish 7/10 Entry $19.61 to $19.78 Now $19.80 +0.97% ▲ +0.87% +0.79% vs SPY
  7. Oct 19, 202628d ago DEFA14A Bullish 8/10 Entry $19.58 to $19.78 Now $19.80 +1.12% ▲ +1.02% +1.17% vs SPY
  8. Oct 19, 202628d ago 8-K Bullish 9/10 Entry $19.58 to $19.78 Now $19.80 +1.12% ▲ +1.02% +1.17% vs SPY
  9. Oct 13, 20264w ago SC 13G/A Neutral 3/10 Entry $8.98 to $19.67 Now $19.80 +120.49% ▲ +119.04% +118.59% vs SPY
  10. Oct 13, 20264w ago SC 13G Neutral 3/10 Entry $8.98 to $19.67 Now $19.80 +120.49% ▲ +119.04% +118.59% vs SPY
Showing 10 of 15

US Market Status

Market Closed · Opens in 6h 33m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026